Topical Skin Adhesive Market

Quick Navigation

• Report Overview
• Key Takeaways
• Driving factors
• Restraining Factors
• By Type Analysis
• By Application Analysis
• Key Market Segments
• Growth Opportunity
• Latest Trends
• Regional Analysis
• Key Players Analysis
• Recent Development
• Report Scope

Report Overview

The Global Topical Skin Adhesive Market was valued at USD 716.5 million in 2023. It is expected to reach USD 1,559.0 million by 2033, with a CAGR of 8.3% during the forecast period from 2024 to 2033.

The Topical Skin Adhesive Market refers to the sector encompassing the production, distribution, and application of adhesive formulations specifically designed for skin bonding in medical, cosmetic, and surgical settings. These adhesives offer a versatile alternative to traditional sutures, staples, or tapes, providing efficient wound closure, reducing procedure time, and enhancing patient comfort.

Market analysis indicates robust growth driven by escalating demand for minimally invasive procedures, technological advancements in adhesive formulations, and a rising preference for non-invasive wound closure solutions. Key stakeholders, including product managers, are urged to monitor this market for its promising opportunities and disruptive innovations.

In the ever-evolving landscape of dermatology and cosmetic procedures, the Topical Skin Adhesive Market emerges as a pivotal segment, witnessing significant traction and poised for substantial growth. Topical skin adhesives serve as an integral component in various medical and cosmetic applications, ranging from wound closure to aesthetic enhancements. This market segment thrives on the increasing demand for minimally invasive procedures, coupled with advancements in adhesive technologies and a growing preference for natural products.

The growth of the Topical Skin Adhesive Market can be attributed to several key factors. Firstly, the rising popularity of skin resurfacing procedures, such as dermabrasion, chemical peels, and laser treatments, has fueled the demand for effective wound closure solutions. In 2022, these procedures recorded a remarkable 21% increase compared to 2019, with 704,992 procedures performed, indicating a burgeoning market opportunity for topical skin adhesives.

Moreover, the surge in skin treatment procedures utilizing combination lasers, including laser hair removal, IPL, and laser tattoo removal, further underscores the need for reliable wound closure methods. With a notable 41% increase in 2022 compared to 2019, totaling 1,187,507 procedures, the demand for top-tier adhesive solutions is poised to escalate.

Additionally, the growing adoption of hyaluronic acid (HA) filler procedures, witnessing a substantial 33% surge in 2022 compared to 2019, with 1,623,031 procedures performed, presents a lucrative avenue for topical skin adhesive manufacturers. As consumers prioritize natural and non-invasive treatment options, the compatibility of topical skin adhesives with HA fillers positions them as preferred choices among clinicians and patients alike.

Key Takeaways

• Market Growth: The Global Topical Skin Adhesive Market was valued at USD 716.5 million in 2023. It is expected to reach USD 1,559.0 million by 2033, with a CAGR of 8.3% during the forecast period from 2024 to 2033.
• By Type: N-2-Butyl-Cyanoacrylate adhesive dominates the market with a 60% share.
• By Application: In surgical applications, it holds a dominant share of 55%.
• Regional Dominance: In North America, the Topical Skin Adhesive Market holds a dominant 33% share.
• Growth Opportunity: In 2023, the global topical skin adhesive market is poised for growth due to increasing chronic wound cases and technological advancements in adhesive formulations, creating lucrative opportunities for market players.

Driving factors

Growing Healthcare Infrastructure Development Costs Fuel Topical Skin Adhesive Market Expansion

The burgeoning expenditure in healthcare infrastructure development plays a pivotal role in propelling the growth of the topical skin adhesive market. As healthcare systems globally modernize and expand, there's a parallel demand surge for advanced wound closure solutions.

With increasing investments in healthcare facilities, such as hospitals, clinics, and ambulatory surgical centers, the need for efficient, safe, and cost-effective wound closure options escalates. Consequently, the topical skin adhesive market witnessed a substantial uptick, supported by the imperative to streamline wound management processes within these evolving healthcare infrastructures.

Enhanced Treatments and Safety Elevate Topical Skin Adhesive Adoption

The continual advancements in topical skin adhesive formulations contribute significantly to market expansion. Manufacturers are relentlessly innovating to enhance the efficacy, durability, and safety profiles of these adhesives, catering to the evolving needs of healthcare practitioners and patients alike. Improved adhesive technologies offer superior wound closure outcomes, reducing the risk of complications and enhancing patient comfort.

Moreover, innovations addressing specific concerns, such as allergic reactions and skin irritation, bolster confidence in these products among healthcare professionals. Consequently, the market experiences a steady growth trajectory as the adoption of topical skin adhesives becomes increasingly widespread across medical specialties and applications.

Surging Demand in Medical Applications Drives Topical Skin Adhesive Market Growth

The escalating demand for medical applications and products underscores the significant role of topical skin adhesives in modern healthcare practices. With a diverse array of applications spanning surgical procedures, wound management, and emergency care, these adhesives have become indispensable tools in the medical arsenal.

The versatility, ease of use, and efficacy of topical skin adhesives make them preferred choices across various medical specialties, driving sustained market growth. Furthermore, the rising prevalence of chronic conditions, coupled with an aging population, amplifies the demand for advanced wound closure solutions, further fuelling the expansion of the topical skin adhesive market.

Restraining Factors

Limited Availability of Effective and Innovative Products Stunts Topical Skin Adhesive Market Growth

The constrained availability of effective and innovative topical skin adhesive products acts as a significant hindrance to market expansion. Despite the growing demand for advanced wound closure solutions, the market faces challenges in delivering a diverse range of products that meet evolving clinical needs. Manufacturers grapple with the complexities of formulating adhesives that strike a balance between efficacy, safety, and patient comfort.

This limitation curtails market growth as healthcare providers may opt for alternative wound closure methods when faced with inadequate product options. Moreover, the absence of novel formulations impedes market penetration into niche medical specialties and applications, constraining revenue generation opportunities within the topical skin adhesive market.

Potential for Adverse Effects and Drug Interactions Dampens Topical Skin Adhesive Market Prospects:

Concerns regarding the potential for adverse effects and drug interactions pose a significant restraint to the growth of the topical skin adhesive market. Despite advancements in adhesive technology, there remains a risk of allergic reactions, skin irritation, and other adverse effects associated with the use of topical skin adhesives. Healthcare providers exercise caution when selecting adhesive products, prioritizing patient safety and minimizing the likelihood of complications.

Additionally, the potential for interactions between topical skin adhesives and other medications further complicates treatment regimens, prompting healthcare professionals to exercise vigilance. Consequently, the market contends with heightened regulatory scrutiny and consumer apprehension, dampening overall market prospects. Addressing these concerns through rigorous safety testing, enhanced product labeling, and clear communication channels is imperative to mitigate market restraints and foster sustained growth in the topical skin adhesive market.

By Type Analysis

N-2-Butyl-Cyanoacrylate adhesive holds a commanding 60% market share by type, showcasing its significant dominance.

In 2023, N-2-Butyl-Cyanoacrylate Adhesive held a dominant market position in the By Type segment of the Topical Skin Adhesive Market, capturing more than a 60% share. This significant market share can be attributed to several factors, including its strong adhesive properties, versatility in medical applications, and widespread availability.

N-2-butyl-cyanoacrylate adhesive is favored by healthcare professionals for its quick-drying nature and ability to form strong bonds, making it ideal for wound closure and surgical procedures. Moreover, its efficacy in promoting wound healing and minimizing scarring further enhances its appeal among both healthcare providers and patients.

Following closely behind N-2-Butyl-Cyanoacrylate Adhesive is 2-Octyl Cyanoacrylate Adhesive, which also commands a notable share of the Topical Skin Adhesive Market. Known for its flexibility and biocompatibility, 2-Octyl Cyanoacrylate Adhesive is commonly used in various medical settings, including emergency rooms, clinics, and operating rooms. Its ability to create a waterproof and microbial barrier over wounds makes it particularly suitable for applications where wound protection is paramount.

Additionally, 2-Ethyl-Cyanoacrylate Adhesive contributes to the diverse landscape of the Topical Skin Adhesive Market, although to a lesser extent compared to its counterparts. This variant of cyanoacrylate adhesive is valued for its fast polymerization rate and strong adhesion properties. While it may not hold as large a market share as N-2-Butyl-Cyanoacrylate or 2-Octyl Cyanoacrylate Adhesive, it still plays a significant role in specific medical procedures and wound closure applications.

By Application Analysis

Within surgical applications, it asserts a leading position with a notable 55% share, demonstrating its efficacy.

In 2023, Surgical held a dominant market position in the By Application segment of the Topical Skin Adhesive Market, capturing more than a 55% share. This significant market dominance reflects the widespread use of topical skin adhesives in various surgical procedures across healthcare facilities worldwide. Surgical applications encompass a broad spectrum of procedures, including wound closure, incision management, and surgical site protection. The preference for topical skin adhesives in surgical settings can be attributed to their ease of application, rapid bonding properties, and ability to provide secure wound closure without the need for sutures or staples.

Following the Surgical segment is Outdoor Medical, which represents a notable portion of the Topical Skin Adhesive Market. Outdoor medical applications include the treatment of minor injuries, lacerations, and abrasions encountered in outdoor activities, sports, and recreational pursuits. Topical skin adhesives offer a convenient and effective solution for wound closure in outdoor environments where traditional wound care methods may be impractical or unavailable. The portability and quick application of topical skin adhesives make them particularly well-suited for addressing minor injuries during outdoor adventures.

Additionally, the Other segment encompasses a variety of niche applications for topical skin adhesives beyond surgical and outdoor medical settings. These applications may include dermatological procedures, veterinary medicine, and industrial uses. While the Other segment may not command as significant a market share as Surgical or Outdoor Medical, it underscores the versatility and adaptability of topical skin adhesives across diverse fields and industries.

Overall, the By Application segment of the Topical Skin Adhesive Market continues to exhibit robust growth, driven by the expanding utilization of topical skin adhesives across a wide range of medical and non-medical applications. The dominance of Surgical applications highlights the pivotal role of topical skin adhesives in modern surgical practices, while the inclusion of Outdoor Medical and Other segments reflects the diverse and evolving nature of the market.

Key Market Segments

By Type

• 2-Octyl Cyanoacrylate Adhesive
• N-2-Butyl-Cyanoacrylate Adhesive
• 2-Ethyl-Cyanoacrylate Adhesive

By Application

• Surgical
• Outdoor Medical
• Other

(Note: We also have reports focused on specific sub-segments. If this piques your interest, please get in touch with us.)

Growth Opportunity

Rising Prevalence of Chronic Wounds

The global topical skin adhesive market is poised for significant growth in 2023, primarily driven by the escalating prevalence of chronic wounds worldwide. With an aging population and increasing incidences of chronic conditions such as diabetes and obesity, the demand for advanced wound closure solutions has surged.

Topical skin adhesives offer several advantages over traditional wound closure methods, including reduced infection risk, improved patient comfort, and faster healing times. As healthcare systems prioritize cost-effective and efficient wound management strategies, the adoption of topical skin adhesives is expected to soar, creating lucrative growth opportunities for market players.

Technological Innovations in Adhesive Formulations

Innovations in adhesive formulations represent another key driver propelling the growth of the global topical skin adhesive market in 2023. Manufacturers are investing in research and development to enhance the properties of topical skin adhesives, such as flexibility, strength, and biocompatibility.

Advanced formulations are being engineered to address specific clinical needs, catering to a diverse range of wound types and patient demographics. Additionally, technological advancements have facilitated the development of applicator systems that improve precision and ease of use, further expanding the market's accessibility and appeal.

Latest Trends

Innovation in Applicator Designs for Improved Precision

The year 2023 witnesses a notable trend in the global topical skin adhesive market, characterized by innovative designs of applicators aimed at enhancing precision during application. Market players are increasingly focusing on developing applicator systems that offer greater control and accuracy, enabling healthcare professionals to apply adhesive with precision, especially in challenging anatomical areas or delicate wound sites.

These advancements not only improve patient outcomes by minimizing tissue trauma but also contribute to operational efficiency within healthcare settings. As precision becomes paramount in wound closure procedures, the demand for advanced applicator designs is expected to drive market growth significantly.

Emphasis on Infection Prevention and Wound Healing

Another prominent trend shaping the global topical skin adhesive market in 2023 is the heightened emphasis on infection prevention and wound healing. With growing recognition of the critical role played by topical skin adhesives in promoting wound closure and reducing the risk of infections, market players are innovating to enhance the antimicrobial properties of adhesive formulations.

Additionally, there is a concerted effort to develop adhesives that accelerate the wound healing process, leveraging advanced biomaterials and bioactive compounds. These developments align with healthcare priorities aimed at improving patient outcomes and reducing healthcare-associated infections, driving the adoption of topical skin adhesives across diverse clinical settings.

Regional Analysis

In North America, the Topical Skin Adhesive Market captures a significant share, constituting 33%.

In the topical skin adhesive market, North America stands as a formidable stronghold, commanding a significant share of approximately 33%. This dominance can be attributed to several factors, including robust healthcare infrastructure, increasing surgical procedures, and growing adoption of advanced medical technologies. The region's emphasis on research and development, coupled with high healthcare expenditure, further bolsters its position in the global market.

Moreover, the prevalence of chronic diseases necessitating surgical interventions, coupled with a rising number of cosmetic procedures, propels the demand for topical skin adhesives across various healthcare settings in North America. The United States, in particular, emerges as a key contributor to market growth, owing to its technologically advanced healthcare facilities and a large patient pool.

In recent years, advancements in topical skin adhesive formulations and application techniques have further fueled market expansion in North America. Manufacturers are continuously innovating to develop products with improved efficacy, reduced toxicity, and enhanced wound healing properties, thereby widening the scope of applications across surgical, trauma, and wound closure procedures.

Furthermore, increasing awareness regarding the benefits of topical skin adhesives in minimizing scarring, reducing infection rates, and accelerating healing processes among healthcare professionals and patients alike fosters market growth in the region. As a result, North America retains its dominance in the global topical skin adhesive market, poised for continued expansion in the foreseeable future.

Key Regions and Countries

North America

• The US
• Canada
• Rest of North America

Europe

• Germany
• France
• The UK
• Spain
• Netherlands
• Russia
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• Singapore
• Thailand
• South Korea
• Vietnam
• India
• New Zealand
• Rest of Asia Pacific

Latin America

• Mexico
• Brazil
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• South Africa
• UAE
• Rest of Middle East & Africa

Key Players Analysis

In 2023, the global Topical Skin Adhesive market showcased robust growth, with key players such as Johnson & Johnson, Medtronic plc, and Advanced Medical Solutions Group Plc leading the forefront. Johnson & Johnson, headquartered in the US, maintained its dominant position through its extensive product portfolio and widespread market penetration. With a strong focus on innovation and research, Johnson & Johnson continued to introduce advanced topical skin adhesive solutions, catering to diverse medical needs globally.

Medtronic plc, based in Ireland, emerged as a formidable competitor in the market, leveraging its technological expertise and strategic collaborations to expand its product offerings. The company's commitment to quality and patient safety propelled its growth trajectory, enabling it to capture significant market share in 2023.

Meanwhile, Advanced Medical Solutions Group Plc, headquartered in the UK, demonstrated notable advancements in topical skin adhesive technology, bolstering its position in the market. With a keen emphasis on sustainability and product efficacy, Advanced Medical Solutions Group Plc fostered strong customer trust and loyalty, driving its revenue growth in the competitive landscape.

Additionally, companies such as Medline Industries, Inc., B. Braun, Chemence Medical, Inc., Adhezion Biomedical, LLC, and Glustich Inc. contributed substantially to the market dynamics, each bringing its unique strengths and capabilities to the forefront. Their collective efforts not only enriched the product landscape but also fueled market expansion, catering to the escalating demand for topical skin adhesive solutions across various medical applications.

Market Key Players

• Johnson & Johnson (US)
• Medtronic plc (Ireland)
• Advanced Medical Solutions Group Plc (UK)
• Medline Industries, Inc. (US)
• B. Braun (Germany)
• Chemence Medical, Inc. (US)
• Adhezion Biomedical, LLC (UK)
• Glustich Inc. (Canada)

Recent Development

• In November 2023, DuPont collaborates with STMicroelectronics to develop Liveo™ Smart Biosensing Patch, a wearable device for remote biosignal monitoring, enhancing patient comfort and performance. Presented at the MEDICA Trade Fair, offering multifunctional sensors for improved cardiac monitoring.
• In September 2023, A 42-year-old woman developed an inflamed rash post double mastectomy due to allergic contact dermatitis (ACD) to surgical skin glue. Treatment involved steroid creams. Dermatology Associates of Tallahassee contributed to diagnosis and treatment.

Report Scope